MacroGenics | MGNX - Market Capitalization


MacroGenics reported $108M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Geron USD 1.07B 193M Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 114M 8M Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Pfizer USD 152.89B 11.32B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 837M 278M Sep/2025